{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T17:31:38Z","timestamp":1767720698450},"reference-count":8,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.ando.2024.01.004","type":"journal-article","created":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T08:39:23Z","timestamp":1705480763000},"page":"319-322","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Posaconazole-induced primary adrenal insufficiency: A rare but real risk"],"prefix":"10.1016","volume":"85","author":[{"given":"Antonia","family":"Precali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavle","family":"Roncevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivana","family":"Kraljevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2024.01.004_bib0045","first-page":"2170484","article-title":"Posaconazole-induced adrenal insufficiency in a case of chronic myelomonocytic leukemia","volume":"2018","author":"Miller","year":"2018","journal-title":"Case Rep Endocrinol"},{"key":"10.1016\/j.ando.2024.01.004_bib0050","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/cen.14109","article-title":"Primary adrenal insufficiency: new genetic causes and their long-term consequences","volume":"92","author":"Buonocore","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2024.01.004_bib0055","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1055\/a-0804-2715","article-title":"An update on Addison's disease","volume":"127","author":"Barthel","year":"2019","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.ando.2024.01.004_bib0060","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s40265-019-01127-8","article-title":"Adverse effects associated with long-term administration of azole antifungal agents","volume":"79","author":"Benitez","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.ando.2024.01.004_bib0080","doi-asserted-by":"crossref","first-page":"620","DOI":"10.3390\/jof7080620","article-title":"Severe posaconazole-induced glucocorticoid deficiency with concurrent pseudohyperaldosteronism: an unfortunate two-for-one special","volume":"7","author":"Villar-Prados","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.ando.2024.01.004_bib0065","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.mmcr.2016.10.002","article-title":"A case of rhino-orbital mucormycosis in diabetes with haematogenous cerebral spread","volume":"13","author":"Snaith","year":"2016","journal-title":"Med Mycol Case Rep"},{"key":"10.1016\/j.ando.2024.01.004_bib0070","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.4158\/ACCR-2019-0176","article-title":"Primary adrenal insufficiency secondary to chronic posaconazole use","volume":"6","author":"Araque","year":"2020","journal-title":"AACE Clin Case Rep"},{"key":"10.1016\/j.ando.2024.01.004_bib0075","first-page":"2","article-title":"Adrenal suppression secondary to interaction of combined inhaled corticosteroid and antifungal agent","volume":"4","author":"Pimentel","year":"2018","journal-title":"AACE Clin Case Rep"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426624000040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426624000040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T10:41:31Z","timestamp":1728470491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426624000040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":8,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0003426624000040"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2024.01.004","relation":{},"ISSN":["0003-4266"],"issn-type":[{"type":"print","value":"0003-4266"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Posaconazole-induced primary adrenal insufficiency: A rare but real risk","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2024.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}